K. Westermark et al., NEUROLOGICAL WILSONS-DISEASE STUDIED WITH MAGNETIC-RESONANCE-IMAGING AND WITH POSITRON EMISSION TOMOGRAPHY USING DOPAMINERGIC MARKERS, Movement disorders, 10(5), 1995, pp. 596-603
Four patients with neurological Wilson's disease were investigated usi
ng magnetic resonance imaging (MRI) and positron emission tomography (
PET), All patients had dystonia as their major clinical manifestation
but also had dysarthria and at the presentation of the disease had cho
reoathetoid movements in at least one limb, A multitracer approach wit
h PET was used to visualize various aspects of dopaminergic function;
[C-11]-(+)nomifensine (NMF), [C-11]raclopride (RAG) and [C-11]-L-DOPA
(one patient). Correlation analysis of RAC and NMF binding as well as
putamen/caudate uptake ratios showed corresponding reductions. The pat
ient investigated with [C-11]-L-DOPA had a normal striatal uptake. Gen
erally, structural changes as shown by MRI corresponded to reductions
both in NMF and RAC binding. There was no evident correspondence betwe
en PET findings and the severity of clinical symptoms seen in the indi
vidual patient, In two patients with discrete neurological impairment
at the time of investigation, PET showed serious presynaptic dopaminer
gic Lesions in the putamen. Our data suggest that the striatal degener
ation seen in Wilson's disease comprises a complex pathology involving
both afferent and efferent projections, The discrete neurological imp
airment seen in some patients with gross striatal pathology might be d
ue to concomitant lesions in functionally counteracting basal ganglia
circuits.